Michael F. Mahoney - 15 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Chairman, President & CEO, Director
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 15 Feb 2023
Net transactions value: -$387,116
Form type: 4
Filing time: 16 Feb 2023, 18:17:13 UTC
Previous filing: 15 Feb 2023
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+18,457	+1%	$0.000000	1,821,337	15 Feb 2023	Direct	F1
transaction	BSX	Common Stock	Tax liability	$387,116	-8,186	-0.45%	$47.29	1,813,151	15 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-18,457	-100%	$0.000000^*	0	15 Feb 2023	Common Stock	18,457		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.